# Polidocanol

## Aethoxysklerol 3% inj 60mg/2mL (專案進口)

| TAH Drug Code      | [IAET3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAET3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Varicose veins.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Medium size varices (up to 6 mm diameter): 0.5 to 1 mL of 2% to 3% solution per injection (maximum: 2 mg/kg/day); may repeat in 7 to 14 days. Reticular/small varices: 0.1 to 0.3 mL of 1% solution per injection (maximum: 2 mg/kg/day); repeat injections may be necessary. Central veins of spider veins: 0.1 to 0.2 mL of 1% solution per injection (maximum: 2 mg/kg/day); repeat injections may be necessary. Spider veins: 0.1 to 0.2 mL of 0.5% solution per injection (maximum: 2 mg/kg/day); repeat injections may be necessary. When using Aethoxysklerol 3 % foam, e.g. for the treatment of the great and small saphenous veins, up to 4 ml (6 mL max. for the great saphenous vein) are injected per puncture. The total daily dose must not be exceeded. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | ‧ known allergy to lauromacrogol 400 or any of the other ingredients of Aethoxysklerol ‧ acute severe systemic diseases (especially if untreated) ‧ immobility ‧ severe arterial occlusive disease (Fontaine stage III and IV) ‧ thromboembolic diseases ‧ high risk of thrombosis (e.g. known hereditary thrombophilia or patients with multiple risk factors such as use of hormonal contraceptives or hormone replacement therapy, obesity, smoking and extended periods of immobility). Moreover, the following absolute contraindication applies to foam sclerotherapy: ‧ known symptomatic patent foramen ovale.                                                                                                                                                  |
| Adverse Effects    | >10%: Local: Hematoma at injection site (42%), irritation at injection site (41%), local discoloration (38%), pain at injection site (24%), local pruritus (19%), warm sensation at injection site (16%) 1% to 10%: Local: Venous thrombosis at injection site (6%) <1%, postmarketing, and/or case reports: Allergic dermatitis, anaphylactic shock, angioedema, asthma, cerebrovascular accident, circulatory shock, confusion, deep vein thrombosis, dizziness, dyspnea, fever, flushing, hypertrichosis, loss of consciousness, migraine, neurologic injury, palpitations, paresthesia, pulmonary embolism, skin hyperpigmentation, tissue necrosis at injection site, urticaria, vasculitis, vasodepressor syncope                                                 |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/polidocanol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

